Senior insider sale
Chief Legal Officer at 4D MOLECULAR THERAPEUTICS, INC. — senior position signals high conviction
$202.3K
16.38K shares
What this filing means
BIZILY SCOTT plans to sell 16.38K shares of 4D MOLECULAR THERAPEUTICS, INC. valued at approximately $202.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001950047-26-006669
Officer· Chief Legal Officer
Since Mar 2022
16.38K
Shares to sell
$202.3K
Approx. market value
6.57K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
6/30/2026
5.75KEmployee Stock Purchase Plan
Cash
11/14/2024
814.00Total acquired6.57K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2026 | Exercise of Stock Options Cash | 5.75K | — |
11/14/2024 | Employee Stock Purchase Plan Cash | 814.00 | — |
| Total | 6.57K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
9.81K
Market value
$117.7K
6/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.57K
Market value
$84.6K
6/30/2026
Total
Units
16.38K
Value
$202.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/23/2026 | 9.81K | $117.7K | — | Completed |
| Planned — Approximate Date | ||||
6/30/2026 | 6.57K | $84.6K | NASDAQ | Planned |
| Total | 16.38K | $202.3K | ||